bio topic Glossary international Standards Organization (ISO) -The international equivalent of CEN. The IS0 was founded in 1946 and is based in Geneva. It has played no direct role in the work of TC 233, but works along broadly similar lines to CEN. IS0 9000 -The general quality standard adopted by the IS0 that describes a set of standards aimed at ensuring good, reliable and consistent performance. It is widely used in the manufacturing and service industries. Good Manufacturing Practice (GMP) -A code of practice covering all aspects of a manufacturing process with the aim of ensuring that products are consistently manufactured to the requisite quality. FDA Codes of Practice -These are laid down by the US Food and Drug Administration for manufacturing processes, and are of particular importance for getting product approval in the USA.
many companies operate to GMP, IS0 9000 and FDA standards (see Glossary). Inevitably, the new CEN standards impinge on these existing standards, but care is being taken to avoid conflict between them. Where good standards already exist (for example, for safety cabinets), current requirements are being incorporated into the CEN standards. Therefore, the resulting standards are likely to complement existing guidelines, such as the biosafety advice of the UK Advisory Committee on Genetic Modification.
The focus on biosafety that drives the CEN standards means that areas not covered by existing standards are now being developed. Although the standards are not meant to be legally binding in the national sense, conflicts of national interest are bound to arise during the consultation process; the CEN will need to sift through the technical and political nature of these comments.
International aspects The new standards have the potential to benefit European biotechnology by giving it a lead in health and safety, environmental and consumer protection; they offer the advantage of a common approach and terminology for standardization. International companies may well prefer to use a European, rather than a nationally based, standard. Indeed, there is a general feeling that companies would now like to see written standards replace informal discussion as a basis for doing business.
Furthermore, there has been little activity in this area in Japan, and the long-awaited paper on US standardization has yet to appear. However, there are indications that the US biotechnology sector feels that the lack of standardization makes it hard to get products onto the market, so it may yet initiate its own programme. Therefore, there is a real opportunity for Europe to take a lead. If industry gets fully involved, the standards could be ofhigh enough quality to be adopted by the ISO. The Netherlands) showed that the frequency of glycolytic oscillations decreases significantly with decreasing concentrations of extracellular mannose. A comparison of this with the change in the mannose-transport rate in mannose-transport assays suggested that the mannose transporter controlled the frequency of the oscillations for some 70%. As the sum of all control coefficients with respect to frequency must equal 100% (RefS 1,2), it is unlikely that PFK-1,6 exerts much control on the frequency; its control cannot exceed 30%. Exit PFK-1,6 as the rate-limiting step.
Glucose transport Does sugar transport also control steady flux? Michael Ciriacy (Heinrich-Heine University, Dusseldorf, Germany) reported that 14 HXT genes in Saccharomyces rerevisiae are homologous to monosaccharidetransporter genes. When HXTI-HXT7 were deleted, glucose uptake and growth on glucose were virtually abolished. The transport V,,,,, of the strains containing only one of the HXTI-HXT7 genes was always lower than that of the wild type, and the growth rate decreased in parallel with V,,,,. However, overexpressing the HXTl gene with the ADHl promoter did not cause an increase in the growth rate beyond that of the wild type, and the growth rate remained lower than the maximum transport rate. It appears that the glucose transporter coefficient of control over growth rate and glycolysis may not be very high.
Strains genes. In many cases, the absence of control appears to be due to a control hierarchy that is outside the metabolic pathway. These include the observations that: overexpression of PFK-I,6 causes a decrease in PFK-2.6 concentration, as well as a decrease in the concentration of fructose 2,6-bisphosphate, which is the product of the PFK-2,6 reaction and an activator of PFK- 1 In view of the subtleties observed in metabolic control, the development of more sophisticated experimental and theoretical tools seems appropriate. Rankin Small (University of Edinburgh, Edinburgh, UK) described two recent advances that have been contributed by Henrik Kacser's group. The so-called deviation index predicts the effects of large changes in enzyme activities with remarkable accuracy. By simultaneously modulating the activity of a number of enzymes in a predictable manner, it should be possible to obtain significant changes in flux. Jay Bailey (ETH, Zurich, Switzerland) introduced non-linear models; he has calculated a single, optimum design for his model of yeast glycolysis, out of the 2's designs that are possible when changes in enzyme activities are restricted to a factor of two, and elasticities are either present or absent.
Flux analysis complements MCA: it can be used to calculate individual reaction rates using metabolic maps and measured input and output flows. Only five fluxes have had to be measured in order to calculate the rates of 58 reactions in S. rerevisiae (Ulrik Schulze, Technical University of Denmark, Lyngby, Denmark (Lund, Sweden) demonstrated that S. rerevisiae could be transformed with xylose reductase from Pi&a, so that it was able to synthesize xylitol from xylose. The yield was improved if limited oxygenation was used, and this reduced the production of acetate from the glucose co-substrate. By transforning with xylitol dehydrogenase as well, S. mrevisiae was able to produce ethanol from xylose, while requiring less glucose. Barre and co-workers (INRA, Montpellier, France) manipulated the redox metabolism of S. cerevisiae by transforming with lactate dehydrogenase from L.actohacillur casei. They found that 40% of the flux could be diverted from ethanol to lactate.
Metabolic pathway engineering is now using conceptual and experimental tools that begin to match the complexity of their object: the living cell.
